Supergene, Llc
Clinical trials sponsored by Supergene, Llc, explained in plain language.
-
New drug could save limbs without surgery in major trial
Disease control Recruiting nowThis study tests whether a clot-dissolving drug called Fortelyzin® can save limbs as well as emergency surgery in people with acute limb ischemia—a sudden blockage of blood flow to a leg. About 170 adults with moderate-to-severe ischemia will receive either the drug directly into…
Phase: PHASE3 • Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 17, 2026 10:18 UTC
-
One shot could save lives: new drug trial for lung clots begins
Disease control Recruiting nowThis study tests a single-dose medicine (staphylokinase) to see if it can prevent death, heart failure, or repeat blood clots in people with a serious type of pulmonary embolism. About 486 adults with intermediate high-risk clots will receive either the drug or a placebo. The goa…
Phase: PHASE3 • Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Massive PE study tests new clot-buster on 20,000 patients
Disease control Recruiting nowThis study is tracking how safe and effective a drug called non-immunogenic staphylokinase is for people with a massive blood clot in the lungs (pulmonary embolism). Researchers will follow 20,000 adults who receive this clot-busting medicine in regular hospital care. The main go…
Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 13, 2026 16:03 UTC